Annual report pursuant to Section 13 and 15(d)

Geographic information

v3.19.3.a.u2
Geographic information
12 Months Ended
Dec. 31, 2019
Geographic information  
Geographic information

Note 14 — Geographic information

Operations by geographic area

Revenue represents recognized income from the GSK Collaboration and License Agreement. All revenue was derived in the United Kingdom.

Long-lived assets (excluding intangibles and financial instruments) were located as follows (in thousands):

December 31, 

December 31, 

    

2019

    

2018

United Kingdom

$

27,367

$

18,828

United States

 

24,490

 

17,290

Total long-lived assets(1)

$

51,857

$

36,118

(1) Clinical materials of $2,503,000 and $3,953,000, included within non-current assets as of December 31, 2019 and 2018, respectively, are not included within the table above because they can easily be transferred between geographic locations.
(2) Operating lease right-of-use assets have been included within the above figures for the year ended December 31, 2019 following the transition to ASC 842.

Major customers:

During the years ended December 31, 2019 and 2018, 100% of revenues were generated from one customer, which was GSK.